Skip to main content

Table 1 Sociodemographics, economic characteristics, and clinical history of women with and without uterine fibroids looking for care at Mirebalais University Hospital’s outpatient department between October first, 2019 to January 31, 2020

From: Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study

 

Fibroids (Yes)(n = 116)

Fibroids (No) (n = 77)

P value

characteristics

n (%) or mean

n (%) or mean

 

Age (mean)

41.3 (20–77)

39.4 (22–75)

0.490

Age category

  

0.013

 20–34

28 (24.1)

31 (40.3)

 

 35–49

70 (60.3)

30 (38.9)

 

 50+

18 (15.5)

16 (20.8)

 

Number of pregnancies

  

0.387

 No pregnancy

28 (24.1)

14 (18.2)

 

 1–3 pregnancies

52 (44.8)

42 (54.5)

 

  > 3 pregnancies

20 (17.2)

11 (14.3)

 

Number of births

  

0.210

 No childbirth

43 (37.1)

22 (28.6)

 

 1–3 childbirths

47 (40.5)

41 (53.2)

 

  > 3 childbirths

11 (9.5)

5 (6.5)

 

Menopause

  

0.550

 No

81 (69.8)

57 (74.0)

 

 Yes

20 (17.2)

11 (14.3)

 

Family history of fibroids

  

< 0.001

 No

25 (21.6)

22 (28.6)

 

 Yes

58 (50.0)

10 (12.9)

 

Patient status

  

0.021

 Follow-up visit

95 (81.9)

72 (93.5)

 

 Initial visit

21 (18.1)

5 (6.5)

 

If follow-up patient

  

0.051

  < 6 months

8 (5.7)

3 (3.9)

 

 6–12 months

15 (9.8)

4 (5.2)

 

  > 12 months

72 (70.9)

65 (84.4)

 

Zone of Residence

  

0.009

 Centre

61 (52.6)

55 (71.4)

 

 Out of central plateau

55 (47.41)

22 (28.6)

 

Type of residence

  

0.266

 Urban

91 (78.5)

55 (71.4)

 

 Rural

25 (21.6)

22 (28.6)

 

Average time per medical appointment/visit (Time to go to the hospital)

  

0.285

  ≤ 2 h

92 (79.3)

65 (84.4)

 

  > 2 h

22 (18.9)

10 (12.9)

 

Means of transport

  

0.016

 Public transport

100 (87.1)

55 (71.4)

 

 Walk

10 (8.6)

17 (22.1)

 

 Private transport

4 (3.5)

5 (6.5)

 

Main profession

  

0.137*

 Small business /market

48 (41.4)

30 (38.9)

 

 Educator

15 (12.9)

7 (9.1)

 

 Nurse

13 (11.2)

14 (18.2)

 

 Farmer

12 (10.3)

2 (2.6)

 

 Other

28 (24.1)

24 (31.2)

 

Health insurance

  

0.094

 No

101 (87.1)

60 (77.9)

 

 Yes

5 (12.9)

17 (22.1)

 

Education

  

0.036

 Primary

27 (23.3)

9 (11.7)

 

 Secondary or higher

74 (63.8)

59 (76.6)

 

Family conflicts

  

0.023

 No

86 (74.1)

67 (87.0)

 

 Yes

27 (23.3)

8 (10.4)

 

Employment status

  

0.744

 Not employed

69 (59.5)

47 (61.0)

 

 Employed

47 (40.5)

29 (37.7)

 

Monthly income

  

0.255

 15.4 USD - ≤206 USD (≤10 USD/day)

102 (87.9)

73 (94.8)

 

  > 206USD (> 10 USD/day)

11 (9.5)

4 (5.2)

 

Income decline (decline observed in the income after the diagnosis of uterine fibroids)

  

< 0.001

 No

49 (42.2)

53 (68.8)

 

 yes

67 (57.8)

24 (31.2)

 

Degree of income decline if income decline observed

  

0.560*

 High

49 (61.5)

1 (1.3)

 

 Moderate

21 (32.3)

5 (6.5)

 

 Low

4 (6.2)

18 (23.4)

 

Major expense categories

  

0.529

 Medical care

23 (19.8)

12 (15.6)

 

 Non-medical care

93 (80.2)

65 (84.4)

 

Excessive transport expenses

  

0.001

 No

10 (8.6)

20 (25.9)

 

 Yes

91 (78.4)

48 (62.3)

 

Clinical diagnostics and complications

 Diagnostic of uterine fibroids

  No

0 (0.0)

77 (39.9)

 

  Yes

116 (60.1)

0 (0.0)

 

 Anemia

  

0.789

  No

55 (47.4)

35 (45.4)

 

  Yes

61 (52.6)

42 (54.6)

 

 Infertility

  

0.197

  No

73 (62.9)

57 (74.0)

 

  Yes

39 (33.6)

20 (25.9)

 

 Deep vein thrombosis

  

0.001

  No

97 (83.6)

76 (98.7)

 

  Yes

18 (15.5)

1 (1.3)

 

 Urinary stone

  

0.972

  No

99 (85.3)

65 (84.4)

 

  Yes

17 (14.7)

11 (14.3)

 

 Hydronephrosis

  

0.246*

  No

110 (94.8)

76 (98.7)

 

  Yes

6 (5.2)

1 (1.3)

 

 Pelvic infection

  

0.168

  No

31 (26.7)

14 (18.2)

 

  Yes

82 (70.7)

61 (79.2)

 
  1. *p-values generated from Fisher’s exact test for cell counts less than 5